424 related articles for article (PubMed ID: 28396235)
1. Innate immunity in Sjögren's syndrome.
Kiripolsky J; McCabe LG; Kramer JM
Clin Immunol; 2017 Sep; 182():4-13. PubMed ID: 28396235
[TBL] [Abstract][Full Text] [Related]
2. Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiation.
Kramer JM
Cytokine; 2014 Jun; 67(2):92-101. PubMed ID: 24656928
[TBL] [Abstract][Full Text] [Related]
3. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
Jin JO; Shinohara Y; Yu Q
PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
[TBL] [Abstract][Full Text] [Related]
4. Protocols for Experimental Sjögren's Syndrome.
Bagavant H; Deshmukh US
Curr Protoc Immunol; 2020 Dec; 131(1):e114. PubMed ID: 33252847
[TBL] [Abstract][Full Text] [Related]
5. Aspects of innate immunity in Sjögren's syndrome.
Low HZ; Witte T
Arthritis Res Ther; 2011 May; 13(3):218. PubMed ID: 21635716
[TBL] [Abstract][Full Text] [Related]
6. Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.
Conti P; Stellin L; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560266
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic and Single-Cell Analysis Reveals Regulatory Networks and Cellular Heterogeneity in Mouse Primary Sjögren's Syndrome Salivary Glands.
Horeth E; Oyelakin A; Song EC; Che M; Bard J; Min S; Kiripolsky J; Kramer JM; Sinha S; Romano RA
Front Immunol; 2021; 12():729040. PubMed ID: 34912329
[TBL] [Abstract][Full Text] [Related]
8. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
9. Central role for marginal zone B cells in an animal model of Sjogren's syndrome.
Shen L; Gao C; Suresh L; Xian Z; Song N; Chaves LD; Yu M; Ambrus JL
Clin Immunol; 2016 Jul; 168():30-36. PubMed ID: 27140729
[TBL] [Abstract][Full Text] [Related]
10. Activation of the type I interferon pathway in primary Sjogren's syndrome.
Mavragani CP; Crow MK
J Autoimmun; 2010 Nov; 35(3):225-31. PubMed ID: 20674271
[TBL] [Abstract][Full Text] [Related]
11. Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.
Srivastava A; Makarenkova HP
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271951
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood gene expression profiling in Sjögren's syndrome.
Emamian ES; Leon JM; Lessard CJ; Grandits M; Baechler EC; Gaffney PM; Segal B; Rhodus NL; Moser KL
Genes Immun; 2009 Jun; 10(4):285-96. PubMed ID: 19404300
[TBL] [Abstract][Full Text] [Related]
14. Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.
Yin H; Cabrera-Perez J; Lai Z; Michael D; Weller M; Swaim WD; Liu X; Catalán MA; Rocha EM; Ismail N; Afione S; Rana NA; Di Pasquale G; Alevizos I; Ambudkar I; Illei GG; Chiorini JA
Arthritis Rheum; 2013 Dec; 65(12):3228-38. PubMed ID: 23982860
[TBL] [Abstract][Full Text] [Related]
15. The Involvement of Innate and Adaptive Immunity in the Initiation and Perpetuation of Sjögren's Syndrome.
Chivasso C; Sarrand J; Perret J; Delporte C; Soyfoo MS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440862
[TBL] [Abstract][Full Text] [Related]
16. Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.
Nandula SR; Scindia YM; Dey P; Bagavant H; Deshmukh US
Oral Dis; 2011 Nov; 17(8):801-7. PubMed ID: 21815968
[TBL] [Abstract][Full Text] [Related]
17. Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren's Syndrome.
Shimizu T; Nakamura H; Kawakami A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803026
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and New Strategies for Primary Sjögren's Syndrome.
Mavragani CP
Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084
[TBL] [Abstract][Full Text] [Related]
19. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
Johnson BC; Morton JI; Trune DR
Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
[TBL] [Abstract][Full Text] [Related]
20. SATB1 Conditional Knockout Results in Sjögren's Syndrome in Mice.
Tanaka Y; Sotome T; Inoue A; Mukozu T; Kuwabara T; Mikami T; Kowhi-Shigematsu T; Kondo M
J Immunol; 2017 Dec; 199(12):4016-4022. PubMed ID: 29127143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
